IGC Pharma (IGC) Raw Materials (2019 - 2026)
IGC Pharma (IGC) posted quarterly Raw Materials of $447000.0 for Q1 2026, down 59.51% year-over-year from $1.1 million in Q1 2025, and little changed quarter-over-quarter from $446000.0 in Q4 2025.
IGC Pharma (IGC) Raw Materials (2019 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Raw Materials for 8 consecutive years, with $447000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Raw Materials fell 59.51% year-over-year to $447000.0; the TTM figure through Mar 2026 stood at $447000.0 (down 59.51% YoY), while the FY2026 annual figure was $447000.0, down 59.51% from the prior year.
- Raw Materials was little changed at $447000.0 in Q1 2026 per IGC's latest filing, from $446000.0 in the prior quarter.
- Across five years, Raw Materials topped out at $2.9 million in Q3 2022 and bottomed at $15000.0 in Q2 2023.
- Historically, Raw Materials has averaged $903705.9 across 5 years, with a median of $472000.0 in 2022.
- Annual changes were most pronounced in 2023 — Raw Materials sank 99.33% — and 2024, when it soared 6581.25%.
- IGC Pharma's Raw Materials stood at $55000.0 in 2022, then sank by 70.91% to $16000.0 in 2023, then jumped by 6581.25% to $1.1 million in 2024, then plunged by 58.28% to $446000.0 in 2025, then gained by 0.22% to $447000.0 in 2026.
- Business Quant data shows IGC's Raw Materials at $447000.0 in Q1 2026, $446000.0 in Q4 2025, and $20000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 447,000.00 |
| Dec 31, 2025 | 446,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 47,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 51,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 2.13 Mn |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 2.10 Mn |
| Dec 31, 2022 | 55,000.00 |
| Sep 30, 2022 | 2.95 Mn |
| Jun 30, 2022 | 2.24 Mn |
| Mar 31, 2022 | 472,000.00 |
| Dec 31, 2021 | 511,000.00 |
| Sep 30, 2021 | 449,000.00 |
| Jun 30, 2021 | 2.33 Mn |